"Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157." Current Pharmaceutical Design , 24(18), 19902001
Put simply, when weighing BPC-157 vs TB-500 , the literature describes BPC-157 as helping build and stabilise the repair infrastructure at a specific location, while TB-500 is described as helping the cells that do repair work travel to wherever they are needed
Does BPC-157 cause cancer
Book a Consultation BPC-157 is believed to interact with the bodys natural healing pathways
Sub-spec marketplace product that started at 0.7% benzyl alcohol instead of 0.9%, or with pH outside the 4.5-7.0 range, doesn't get the full 28-day window even with perfect storage
Researchers are responsible for compliance with all applicable local, state, and federal regulations